Asterias Biotherapeutics
-$0.005 (-0.53%) As of 8:00 PM UTC today
Why Robinhood?
You can watch AST and buy or sell other stocks, options, and ETFs commission-free!
About AST
Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases.
CEO
Brian M. Culley, MBA
Employees
—
Headquarters
Carlsbad, California
Founded
2012
AST Key Statistics
Market cap
92.97M
Price-Earnings ratio
—
Dividend yield
—
Average volume
81.23K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$3.75
52 Week low
$1.20